MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0064755
Zymeth Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.21 Cr
▲ 174% YoY
Net profit · FY 2025
₹16.5 Lakh
Net margin 1.8%
EBITDA · FY 2025
₹36.75 Lakh
EBITDA margin 4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Zymeth Pharmaceuticals Private Limited
Data last updated:
Zymeth Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2019PTC106803. Its GSTIN is 24AABCZ3341H1ZI (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pankaj Maganbhai Parmar (Managing Director) and Ramuben Maganbhai Parmar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 902 Shapath – V Opp. Karnavati Club Sg Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.21 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹16.5 Lakh (net margin 1.8%) and EBITDA of ₹36.75 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 35% over five years.
Zymeth Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0064755). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zymeth.com.
Company details
CIN U24299GJ2019PTC106803
Registration Number 106803
Incorporation Date 25 February 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0064755
Key People
Pankaj Maganbhai Parmar Managing Director Vishakha Rameshbhai Ambaliya Additional Director Ramuben Maganbhai Parmar Director Recognitions & Rankings of Zymeth Pharmaceuticals
Contact details
Zymeth Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is zymeth.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address902 Shapath – V Opp. Karnavati Club Sg Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zymeth Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Zymeth Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Zymeth Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zymeth Pharmaceuticals Private Limited, buy the company report.
Financials of Zymeth Pharmaceuticals Private Limited
FY 2025 filings availableZymeth Pharmaceuticals Private Limited reported revenue of ₹9.21 Cr (up 174% YoY) for FY 2025.
Revenue · FY 2025
₹9.21 Cr ▲ 174%
Net profit · FY 2025
₹16.5 Lakh margin 1.8%
EBITDA · FY 2025
₹36.75 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 174%
3 years · compounded
▲ 12%
5 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 77%
3 years · compounded
▲ 18%
5 years · compounded
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 174% growth in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zymeth Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zymeth Pharmaceuticals Private Limited
Zymeth Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishakha Rameshbhai Ambaliya | Additional Director | 02 Dec 2023 | 2 Years 11 Months | Current |
| Pankaj Maganbhai Parmar | Managing Director | 25 Feb 2019 | 7 Years 8 Months | Current |
| Ramuben Maganbhai Parmar | Director | 25 Feb 2019 | 7 Years 8 Months | Current |
Auditor
Zymeth Pharmaceuticals Private Limited is audited by V S S B & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V S S B & ASSOCIATES | FY 2022 | 121356W |
Shareholding
The shareholding of Zymeth Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Zymeth Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zymeth Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Zymeth Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 9 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| HBR Packaging | |||
| Sonata Rubber Private Limited | |||
| Espee Pharma Chem Private Limited | |||
| an individual supplier | |||
| Premium Paper Products |
To see the full MSME payment records of Zymeth Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Zymeth Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCZ3341H1ZI | Gujarat | Active | 13 Mar 2019 |
To see the full GST registrations and return filing status of Zymeth Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zymeth Pharmaceuticals Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Vishakha Rameshbhai Ambaliya was appointed as Additional Director on 02 Dec 2023.
AGM
Zymeth Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zymeth Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Vishakha Rameshbhai Ambaliya was appointed as Additional Director.
Ceased
Pankaj Maganbhai Parmar ceased to be Director.
Appointed
Pankaj Maganbhai Parmar was appointed as Managing Director.
Appointed
Ramuben Maganbhai Parmar was appointed as Director.
Incorporation
25 Feb 2019
Zymeth Pharmaceuticals Private Limited was registered on 25 Feb 2019 with Roc Ahmedabad & aged 7 years 8 months as per MCA records.
Frequently asked questions
Zymeth Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2019 (7+ years old) and is registered under CIN U24299GJ2019PTC106803.
Zymeth Pharmaceuticals has 3 current directors:
- Pankaj Maganbhai Parmar - Managing Director
- Vishakha Rameshbhai Ambaliya - Additional Director
- Ramuben Maganbhai Parmar - Director
The latest financial statements of Zymeth Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zymeth Pharmaceuticals is 24AABCZ3341H1ZI, registered in Gujarat.
The CIN (Corporate Identification Number) of Zymeth Pharmaceuticals is U24299GJ2019PTC106803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zymeth Pharmaceuticals was incorporated on 25 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Vishakha Rameshbhai Ambaliya was appointed as Additional Director on 02 Dec 2023. Pankaj Maganbhai Parmar ceased to be Director on 09 Mar 2019. Pankaj Maganbhai Parmar was appointed as Managing Director on 25 Feb 2019. Zymeth Pharmaceuticals has 4 board changes on record in total.
Yes, Zymeth Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0064755).
Zymeth Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 9 overdue payments to 9 micro and small suppliers. The latest return was filed on 02 Oct 2020.
Zymeth Pharmaceuticals can be reached through the website zymeth.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Zymeth Pharmaceuticals is at 902 Shapath – V Opp. Karnavati Club Sg Highway, Ahmedabad, Gujarat, India – 380015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages